We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

GF:SIXGeorg Fischer AG Analysis

Data as of 2026-03-11 - not real-time

$11.27

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

The New Germany Fund (GF) trades at a **trailing P/E of 1.85**, dramatically below the industry average of 17, and a **price‑to‑book of 0.84**, indicating deep value relative to peers. Operating margins of 63% and a ROE of 31% underscore strong profitability, while a modest dividend yield of 1.34% with a payout ratio of just 1.1% suggests the payout is highly sustainable. The fund’s **beta of 0.64** points to lower systematic risk than the market, yet a 30‑day volatility of 23% signals notable price swings. Technicals show a **neutral trend**, with the 20‑day SMA (11.78) slightly below the current price (11.27) and the 50‑day SMA (11.86) above, while the RSI at 39 hints at mild oversold conditions. However, the **MACD histogram is negative** and volume is decreasing, indicating bearish momentum in the short run. The market sentiment index reads “Extreme Greed,” reflecting bullish investor bias despite the stock’s modest price action. Support sits at 10.52 and resistance at 12.32, giving the price a relatively wide trading range. Overall, the fund combines strong fundamentals with a compelling valuation gap, but technical weakness and liquidity constraints temper enthusiasm.
Given the low debt, solid cash position, and exposure to German small‑ and mid‑cap equities, GF offers a value‑oriented play that could benefit from a market correction or renewed interest in undervalued European assets. Investors should weigh the modest liquidity and bearish short‑term signals against the attractive valuation and dividend sustainability when deciding on positioning.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bearish MACD and decreasing volume
  • RSI near oversold levels
  • Price above support but below resistance

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Significant valuation discount (P/E 1.85 vs industry 17)
  • Strong profitability and low debt
  • Sustainable dividend with very low payout ratio

Long Term

> 3 years
Positive
Model confidence: 8/10

Key Factors

  • Consistent earnings generation and high ROE
  • Exposure to German mid‑cap growth potential
  • Low beta and defensive financial‑services sector profile

Key Metrics & Analysis

Financial Health

Revenue Growth7.80%
Profit Margin1679.99%
P/E Ratio1.9
ROE30.96%
ROA0.36%
P/B Ratio0.8
Industry P/E17.1

Technical Analysis

TrendNeutral
RSI39.2
Support$10.52
Resistance$12.32
MA 20$11.78
MA 50$11.86
MA 200$11.58
MACDBearish
VolumeDecreasing
Fear & Greed Index76.77

Valuation

GradeUndervalued
TypeValue
Dividend Yield1.34%

Risk Assessment

Beta0.64
Volatility23.41%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskHigh

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.